Telix Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TELIX, and what generic alternatives to TELIX drugs are available?
TELIX has one approved drug.
There is one US patent protecting TELIX drugs.
There are thirty-nine patent family members on TELIX drugs in eighteen countries.
Summary for Telix
| International Patents: | 39 |
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Telix
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Telix | ILLUCCIX | gallium ga-68 gozetotide | POWDER;INTRAVENOUS | 214032-001 | Dec 17, 2021 | RX | Yes | Yes | 11,027,031 | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Telix Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2016030103 | ⤷ Subscribe |
| Russian Federation | 2724894 | ⤷ Subscribe |
| Canada | 2958475 | ⤷ Subscribe |
| Israel | 250735 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
